INSTITUTO FINLAY DE VACUNAS

Trials shown by sponsor

Public title	Date of Registration	State
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2	22/05/2020	Registered
To evaluate the immunogenicity and safety of SOBERANA® 02 and SOBERANA® Plus as booster of immunity against the omicrom variant of SARS-CoV-2, in adult subjects	19/05/2023	Registered
Study on pneunococcal vaccination in the pediatric population from 1 year to 5 years	03/08/2023	Registered
Study of the tetanus vaccine vax-TET®-5	2013-06-10	Registered
Study of the meningococcal ACW135 polysaccharide vaccine	04/12/2015	Registered
SOBERANA PLUS TURIN	12/11/2021	Registered outdated
SOBERANA PLUS PEDIATRIA	28/09/2021	Registered outdated
SOBERANA PLUS	09/04/2021	Registered
SOBERANA PEDIATRIA CLINICA 1	23/07/2021	Registered outdated
SOBERANA PEDIATRIA	10/06/2021	Registered
SOBERANA CENTRO	23/07/2021	Registered outdated
SOBERANA 02A	17/12/2020	Registered outdated
SOBERANA 02-FaseIII	03/03/2021	Registered
SOBERANA 02	27/10/2020	Registered
SOBERANA 01B	05/01/2021	Registered
SOBERANA 01A	17/10/2020	Registered
SOBERANA 01	13/08/2020	Registered outdated
SOBERANA - INTERVENTION	19/03/2021	Registered
Sinopharm-SOBERANA COVID-Cienfuegos	30/08/2022	Registered
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II.	28/04/2017	Registered outdated